Join
Live feed
·
PRReleasevia Quantisnow
Zealand Pharma A/S logo
Royalty Pharma plc logo

Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ZEAL (Zealand Pharma A/S), RPRX (Royalty Pharma plc) and more on Quantisnow.